Publications by authors named "Nora K Horick"

29Publications

Integrating Systems Into the Diagnostic Criteria for Breast Cancer-Related Lymphedema: Applying Results From a Prospective Surveillance Program.

Phys Ther 2020 Sep 15. Epub 2020 Sep 15.

Department of Radiation Oncology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114 (USA).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ptj/pzaa162DOI Listing
September 2020

Screening Tool Identifies Older Adults With Cancer at Risk for Poor Outcomes.

J Natl Compr Canc Netw 2020 03;18(3):305-313

Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2019.7355DOI Listing
March 2020

The Impact of Chest Wall Boost on Reconstruction Complications and Local Control in Patients Treated for Breast Cancer.

Int J Radiat Oncol Biol Phys 2019 09 2;105(1):155-164. Epub 2019 May 2.

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.04.027DOI Listing
September 2019

Are rare cancer survivors at elevated risk of subsequent new cancers?

BMC Cancer 2019 Feb 21;19(1):166. Epub 2019 Feb 21.

Department of Medicine, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-5358-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385466PMC
February 2019

Physical symptoms in long-term survivors of rare cancer.

J Cancer Surviv 2018 12 12;12(6):835-842. Epub 2018 Oct 12.

Massachusetts General Hospital Biostatistics Center, 50 Staniford St. Suite 560, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11764-018-0721-9
Publisher Site
http://dx.doi.org/10.1007/s11764-018-0721-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503956PMC
December 2018

Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung Cancer.

J Thorac Oncol 2018 04 31;13(4):550-558. Epub 2018 Jan 31.

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183003
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.01.012DOI Listing
April 2018

Physical and psychological health in rare cancer survivors.

J Cancer Surviv 2017 02 19;11(1):158-165. Epub 2016 Oct 19.

Massachusetts General Hospital Biostatistics Center, 50 Staniford St. Suite 560, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-016-0573-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896295PMC
February 2017

Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.

Cancer 2016 Nov 15;122(21):3297-3306. Epub 2016 Jul 15.

Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30196DOI Listing
November 2016

Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.

J Genet Couns 2017 02 6;26(1):79-92. Epub 2016 Jun 6.

Department of Clinical Sciences and Harold C Simmons Cancer Center, University of Texas - Southwestern, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-016-9981-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5140768PMC
February 2017

Long-term risk of medical conditions associated with breast cancer treatment.

Breast Cancer Res Treat 2014 May 3;145(1):233-43. Epub 2014 Apr 3.

Department of Internal Medicine and Cancer Research and Treatment Center, University of New Mexico, MSC 10-5550, Albuquerque, NM, 87131-0001, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2928-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096572PMC
May 2014

Peptide-mediated selective adhesion of smooth muscle and endothelial cells in microfluidic shear flow.

Langmuir 2007 Apr 21;23(9):5050-5. Epub 2007 Mar 21.

Department of Chemical Engineering, Northeastern University, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/la0700220DOI Listing
April 2007

Pooling of case specimens to create standard serum sets for screening cancer biomarkers.

Cancer Epidemiol Biomarkers Prev 2007 Feb;16(2):334-41

Biostatistics Center, Massachusetts General Hospital, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-06-0681DOI Listing
February 2007

Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.

Clin Cancer Res 2006 Jan;12(2):432-41

Laboratory of Gynecologic Oncology, Department of Obstetrics and Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Dana-Farber Cancer Center, 221 Longwood Avenue, LMRC-601B, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-0461DOI Listing
January 2006

Phase II trial of anastrozole in women with asymptomatic müllerian cancer.

Gynecol Oncol 2003 Dec;91(3):596-602

Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2003.08.021DOI Listing
December 2003

Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.

Clin Cancer Res 2003 Aug;9(8):2904-11

Department of Obstetrics & Gynecology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Harvard Cancer Center, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
August 2003